1Hargreavet B, Hegnesc F, Kendrick SW. Mortality after transurethral and open prostatectomy in Scothnd. Bri Jf Urol, 1996, 77(3):547.
2Lam JS, Romas NA, Lowe FC. Long - term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10 - year follow - up.Urology, .2003, 61:354.
3Foley SJ, Solomam LZ, Wedderbum AW, et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol, 2000, 163(2):496.
4Pareek G, Shevchuk M, Armenakas NA, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel.density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol, 2003, 169(1):20.
5Hagerty JA, Ginsberg PC, Harmon JD, et al. Pretteatent with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate. Urology, 2000, 55(5):684.
6Donohue JF, Sharma H, Abraham R, et al. Transurethral prostate resection and bleeding: a randomized, placebo cantrolled trial of role of finasteride for decreasing operative blood loss. J Urol, 2002, 168(5):2024.
